Bictegravir Use During Pregnancy: A Multi-Center Retrospective Analysis Evaluating HIV Viral Suppression and Perinatal Outcomes.
Lauren M HoltWilliam R ShortFlorence MomplaisirEleanor HyunJennifer R McKinneyAndrea Lugo MoralesAlejandra DuqueBrian DruyanChima NdubizuLuthita DuthelyNaima JosephAnandi ShethMartina L BadellPublished in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2024)
This study describes the largest cohort to date (n=147) of pregnant patients living with HIV on bictegravir (BIC). BIC in pregnancy was associated with high levels of viral suppression and similar perinatal outcomes to published literature. These findings support consideration for use of BIC in management of HIV during pregnancy.
Keyphrases
- antiretroviral therapy
- hiv positive
- pregnant women
- hiv infected
- human immunodeficiency virus
- hiv testing
- end stage renal disease
- sars cov
- hepatitis c virus
- hiv aids
- newly diagnosed
- ejection fraction
- chronic kidney disease
- systematic review
- men who have sex with men
- prognostic factors
- preterm birth
- randomized controlled trial
- type diabetes
- south africa